Pages that link to "Q33532663"
Jump to navigation
Jump to search
The following pages link to Co-morbidity and age-related prevalence of psoriasis: Analysis of health insurance data in Germany (Q33532663):
Displaying 50 items.
- The German National Program on Psoriasis Health Care 2005-2015: results and experiences (Q26751448) (← links)
- Diagnosis of Atopic Dermatitis: Mimics, Overlaps, and Complications (Q26799526) (← links)
- Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis (Q27693878) (← links)
- Biologic safety in psoriasis: review of long-term safety data (Q30904076) (← links)
- Psoriasis and metabolic syndrome in children: current data (Q31152353) (← links)
- The Role of IL-17 in the Pathogenesis and Treatment of Psoriasis (Q33574671) (← links)
- Prevalence and risk factors of actinic keratoses in Germany--analysis of multisource data (Q34561034) (← links)
- Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis (Q34643790) (← links)
- Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review (Q34812877) (← links)
- Add-on effect of chinese herbal medicine bath to phototherapy for psoriasis vulgaris: a systematic review (Q34975485) (← links)
- Childhood psoriasis--an analysis of German health insurance data (Q35013210) (← links)
- Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women (Q35370653) (← links)
- Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom (Q35753936) (← links)
- Nail psoriasis as a severity indicator: results from the PsoReal study (Q36160601) (← links)
- Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest (Q36275101) (← links)
- Comorbid conditions in psoriasis - Higher frequency in females: A prospective study (Q36349516) (← links)
- Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. (Q36552806) (← links)
- Improvements in patient-reported outcomes with apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of moderate to severe psoriasis: results from a phase IIb randomized, controlled study (Q36866954) (← links)
- Psoriasis severity and the prevalence of major medical comorbidity: a population-based study (Q37239394) (← links)
- Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey (Q37268881) (← links)
- Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach (Q37542804) (← links)
- Predictors of biologic treatment of psoriasis: a non-interventional study (Q37600690) (← links)
- Metabolic Syndrome in Psoriasis among Urban South Indians: A Case Control Study Using SAM-NCEP Criteria (Q37734265) (← links)
- Therapy of psoriasis in childhood and adolescence ‐ a German expert consensus (Q37876489) (← links)
- Adherence in the Treatment of Psoriasis: A Systematic Review (Q37901280) (← links)
- Management of psoriasis and its comorbidities in primary care (Q37954016) (← links)
- Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement (Q37961072) (← links)
- The concept of psoriasis as a systemic inflammation: implications for disease management (Q37987268) (← links)
- The association between psoriasis and dyslipidaemia: a systematic review (Q38056160) (← links)
- Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. (Q38058361) (← links)
- The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies (Q38064779) (← links)
- Examining the risk of cardiovascular disease in patients with psoriasis: a critical review. (Q38098647) (← links)
- Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis (Q38114903) (← links)
- Quality of life in psoriasis patients (Q38211301) (← links)
- Psoriasis treatment and management - a systematic review of full economic evaluations (Q38260967) (← links)
- Importance of basic therapy in psoriasis (Q38445629) (← links)
- Apremilast for the treatment of psoriasis (Q38561061) (← links)
- Barriers to guideline-compliant psoriasis care: analyses and concepts (Q38625686) (← links)
- An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies (Q38673766) (← links)
- microRNA-130a Promotes Human Keratinocyte Viability and Migration and Inhibits Apoptosis Through Direct Regulation of STK40-Mediated NF-κB Pathway and Indirect Regulation of SOX9-Meditated JNK/MAPK Pathway: A Potential Role in Psoriasis (Q38721463) (← links)
- Dermatological comorbidity in psoriasis: results from a large-scale cohort of employees (Q38839027) (← links)
- Evidence for the association of Hashimoto's thyroiditis with psoriasis: a cross-sectional retrospective study (Q38952171) (← links)
- Patients' perspectives in the management of psoriasis: the Italian results of the Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) survey. (Q39165009) (← links)
- Treatment patterns in moderate-to-severe plaque psoriasis: results from a Belgian cross-sectional study (DISCOVER). (Q39239428) (← links)
- Metabolic syndrome in Moroccan patients with psoriasis (Q39248840) (← links)
- "Inflammatory skin march" in atopic dermatitis and psoriasis (Q39377564) (← links)
- Prevalence and comorbidities in adults with psoriasis compared to atopic eczema (Q39493546) (← links)
- Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study. (Q39935531) (← links)
- Retrospective analysis of the effectiveness and costs of traditional treatments for moderate-to-severe psoriasis: A single-center, Italian study (Q40046329) (← links)
- Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis (Q40427746) (← links)